Epidyolex® in Lennox Gastaut, Dravet Syndrome and Tuberous Sclerosis Complex: an Observational Study in ITALY

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

February 24, 2025

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2026

Conditions
Lennox Gastaut SyndromeDravet SyndromeTuberous Sclerosis Complex
Interventions
DRUG

Epidiolex 100 mg/mL Oral Solution

As prescribed in routine clinical practice in Italy.

Trial Locations (18)

10126

RECRUITING

AOU Città della Salute PO Molinette, Torino

16147

RECRUITING

Istituto Gaslini Neurologia Pediatrica e Malattie Muscolari, Genova

20142

RECRUITING

Centro Regionale Epilessia - ASST Santi Paolo e Carlo, Milan

20162

RECRUITING

ASST Grande Ospedale metropolitano Niguarda, Milan

28100

RECRUITING

AOU Maggiore della Carità di Novara, Novara

35128

RECRUITING

AOU di Padova, Padua

40138

RECRUITING

Policlinico Sant'Orsola di Bologna, Bologna

50139

RECRUITING

Azienda Ospedaliera Universitaria Meyer Neurologia Pediatrica, Florence

60126

NOT_YET_RECRUITING

Azienda Ospedaliero Universitaria delle Marche, Torrette

66100

RECRUITING

"Università degli studi G. D'annunzio Chieti", Chieti

71013

RECRUITING

Ospedale Casa del sollievo e della sofferenza, San Giovanni Rotondo

80131

NOT_YET_RECRUITING

Azienda Ospedaliera Universitaria Federico II, Napoli

88100

RECRUITING

NPI AOU Mater Domini Università Magna Graecia, Catanzaro

98124

RECRUITING

AOU Gaetano Martino, Messina

00133

RECRUITING

Policlinico Tor Vergata, Roma

00165

RECRUITING

IRCCS Ospedale Pediatrico Bambin Gesù, Roma

00168

RECRUITING

Fondazione Policlinico Universitario Agostino Gemelli - IRCCS-NPI, Roma

00189

NOT_YET_RECRUITING

Azienda Ospedaliero Universitaria Sant'Andrea, Roma

Sponsors
All Listed Sponsors
collaborator

Advice Pharma Group srl

INDUSTRY

lead

Jazz Pharmaceuticals

INDUSTRY